West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...

West Pharmaceutical Services (WST) stock was upgraded to Buy at Deutsche Bank due to an attractive entry point post-selloff. Read more here.

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

West Pharmaceutical Services, Inc. reported an EPS of $1.82, beating the estimated $1.71 and showcasing its ability to exceed expectations. The company achieved a revenue of approximately $748.8 ...

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

KeyBanc analyst Paul Knight maintained a Buy rating on West Pharmaceutical Services (WST – Research Report) today and set a price target of ...

Trade Desk sinks following a revenue miss, AppLovin surges after quarterly revenue soars 44%, and Intel extends the stock’s ...

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...